Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$592M |
| 2 |
Advanced Micro Devices
AMD
|
+$510M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$427M |
| 4 |
Paychex
PAYX
|
+$383M |
| 5 |
MetLife
MET
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$1.18B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$576M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$564M |
| 4 |
Apple
AAPL
|
+$555M |
| 5 |
JPMorgan Chase
JPM
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.21% |
| 2 | Healthcare | 13.42% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Standard BioTools
LAB
$284M
| $1.01M | ﹤0.01% |
280,186
-6,815
| -2% | -$23.5K |
|
|
EIGR
3302
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1M | ﹤0.01% |
4,037
-183
| -4% | -$28.9K |
|
3303
Rush Enterprises Class B
RUSHB
$9.28B
| $1M | ﹤0.01% |
31,140
-867
| -3% | -$28.8K |
|
3304
Dream Finders Homes
DFH
$1.39B
| $1M | ﹤0.01% |
58,685
+4,776
| +9% | +$91.8K |
|
3305
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.4B
| $1M | ﹤0.01% |
20,469
+11,859
| +138% | +$587K |
|
3306
Kura Sushi USA
KRUS
$646M
| $995K | ﹤0.01% |
18,041
+6,321
| +54% | +$326K |
|
3307
CarParts.com
PRTS
$49.4M
| $995K | ﹤0.01% |
14,855
| – | – |
|
|
IMGO
3308
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $995K | ﹤0.01% |
51,629
+23,661
| +85% | +$491K |
|
3309
ACNB Corp
ACNB
$657M
| $993K | ﹤0.01% |
28,411
+891
| +3% | +$29.5K |
|
3310
Vanguard Financials ETF
VFH
$14B
| $993K | ﹤0.01% |
10,639
-4,741
| -31% | -$454K |
|
3311
Park-Ohio Holdings
PKOH
$706M
| $991K | ﹤0.01% |
70,469
+861
| +1% | +$15.5K |
|
3312
WisdomTree US LargeCap Dividend Fund
DLN
$6.45B
| $990K | ﹤0.01% |
15,051
-10,782
| -42% | -$698K |
|
3313
Payoneer
PAYO
$2.42B
| $990K | ﹤0.01% |
222,014
-4,241
| -2% | -$21.4K |
|
|
URG
3314
Ur-Energy
URG
$537M
| $990K | ﹤0.01% |
618,839
+193,783
| +46% | +$274K |
|
|
GTHX
3315
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $990K | ﹤0.01% |
130,270
+301
| +0.2% | +$2.85K |
|
3316
Safe Bulkers
SB
$789M
| $988K | ﹤0.01% |
207,639
-3,770
| -2% | -$15.4K |
|
3317
Vanguard Industrials ETF
VIS
$8.54B
| $987K | ﹤0.01% |
5,080
-1,977
| -28% | -$380K |
|
3318
Warby Parker
WRBY
$3.15B
| $986K | ﹤0.01% |
29,167
+5,641
| +24% | +$182K |
|
3319
Hurco Companies Inc
HURC
$144M
| $984K | ﹤0.01% |
31,213
+858
| +3% | +$27.9K |
|
3320
Viking Therapeutics
VKTX
$3.85B
| $977K | ﹤0.01% |
325,748
+67,835
| +26% | +$243K |
|
3321
Cullinan Oncology
CGEM
$1.25B
| $975K | ﹤0.01% |
93,184
-2,239
| -2% | -$30.3K |
|
3322
Vanguard Communication Services ETF
VOX
$5.9B
| $974K | ﹤0.01% |
8,115
+392
| +5% | +$48K |
|
3323
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
| $972K | ﹤0.01% |
28,338
-6,027
| -18% | -$209K |
|
3324
Richardson Electronics
RELL
$299M
| $970K | ﹤0.01% |
77,963
+22,793
| +41% | +$284K |
|
3325
EyePoint Inc
EYPT
$1.21B
| $966K | ﹤0.01% |
79,407
+3,985
| +5% | +$43.7K |
|
Similar funds
Bank of New York Mellon's Q1 2022 Portfolio in Review
As of Q1 2022, Bank of New York Mellon held 4,798 positions worth $516B, down 6.9% from $554B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q1 2022 filing shows 182 new, 1,981 increased, 2,086 reduced and 146 closed positions. Its largest new stake was Constellation Energy: 6,682,470 shares worth $376M. The largest sale was Oracle, an estimated $1.18B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2022 buy was Constellation Energy: 6,682,470 shares worth $376M.
- Bank of New York Mellon added most to S&P Global in Q1 2022, an estimated $592M increase.
- Bank of New York Mellon's biggest Q1 2022 reduction was Oracle, cutting an estimated $1.18B.
- Bank of New York Mellon fully exited Xilinx Inc in Q1 2022, selling an estimated $576M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $516B portfolio in Q1 2022.
- Bank of New York Mellon opened 182 new positions and closed 146 in Q1 2022.
- Bank of New York Mellon's portfolio value fell 6.9% quarter-over-quarter to $516B.
Based on Bank of New York Mellon's 13F filing for Q1 2022, filed 11 May 2022.